14 reports

Competitive Landscape ##. ## Abbvie ##. ## Biogen Idec ##. ## Bristol-Myers Squibb ##. ## Celgene ##. ## Celltrion ##. ## J& J ##. ## MedImmune ##. ## Merck ##. ## Novartis ##. ## Takeda List of Figures Figure ##-##: Representation of the Disease Progression in Rheumatoid Arthritis Figure ##-

  • Anti Rheumatic
  • Arthritis
  • Therapy
  • World

In more severe cases disease modifying anti-rheumatic drugs (DMARDs) may be prescribed.

  • Anti Rheumatic
  • Autoimmune Disease
  • Therapy
  • United States
  • World

In moderate to severe cases the treatment involves disease-modifying antirheumatic drugs (DMARDs), such as methotrexate (Rheumatrex®).

  • Anti Rheumatic
  • Monoclonal Antibody
  • Therapy
  • United States
  • World

Some of these biologics are approved and used in more than one conditions.

  • Anti Rheumatic
  • Autoimmune Disease
  • Therapy
  • United States
  • World

Retail Pharmacies ## Figure ## ##: Drug Prices - Retail Vs Veteran, 2017, U. S. (## of ##) ## Figure ## ##: Drug Prices - Retail Vs Veteran, 2017, U. S. (## of ##) ## Chart ## ##: Drug Prices - Retail Vs Veteran, 2017, U. S. ## Figure ## ##: Ulcerative Colitis Market by Segment, U. S., 2014 –

  • Anti Rheumatic
  • Monoclonal Antibody
  • Therapy
  • United States
  • World

Hoffmann-La Roche ##. ## GlaxoSmithKline ##. ## Johnson & Johnson ##. ## Novartis ##. ## Pfizer Inc. ##. ## Roche ##. ## Sanofi ##. ## UCB ##. ## Vertex ## Appendix ## Disclaimer List of Tables Table ## Global Rheumatoid Arthritis Market Analysis, by Region, 2013-2022 ($MN) Table ## Global Rheum

  • Anti Rheumatic
  • APAC
  • North America
  • World
  • Market Size

The initial treatment option is disease-modifying antirheumatic drugs, also known as DMARDs.

  • Anti Rheumatic
  • Arthritis
  • Monoclonal Antibody
  • Therapy
  • United States

Retail Pharmacies ## Figure ## ##: Drug Prices - Retail Vs Veteran, 2017, U. S. (## of ##) ## Figure ## ##: Drug Prices - Retail Vs Veteran, 2017, U. S. (## of ##) ## Chart ## ##: Drug Prices - Retail Vs Veteran, 2017, U. S. ## Figure ## ##: Crohn’s Disease Market by Segment, U. S., 2014 – ##

  • Anti Rheumatic
  • Monoclonal Antibody
  • Pathology
  • Therapy
  • United States

Some of these biologics are approved and used in more than one conditions.

  • Anti Rheumatic
  • Autoimmune Disease
  • Therapy
  • United States
  • Market Size
  • 4.1 Changes to Conventional Synthetic Disease Modifying Anti-Rheumatic Drugs, 2015-2022
  • 5.1 Abbreviations

Rheumatoid Arthritis - Heat Map and Analysis Summary Rheumatoid Arthritis (RA) is a chronic, progressive and currently incurable autoimmune disease that primarily affects the joints. Disease progression results in stiffness and pain, especially in the hands and feet, which hinders the mobility of the patient and can have...

  • Anti Rheumatic
  • Therapy
  • Japan

##: Total axial spondyloarthritis sales across the US, Japan, and five major EU markets, by country, 2016–## ## Figure ##: Total axial spondyloarthritis sales in the US, 2016–## ## Figure ##: Total axial spondyloarthritis sales across the five major EU markets, 2016–## ## Figure ##: Total axial

  • Anti Rheumatic
  • Therapy
  • European Union
  • Japan
  • United States
  • LATEST CLINICAL TRIALS NEWS ON JUVENILE RHEUMATOID ARTHRITIS
  • CLINICAL TRIAL PROFILE SNAPSHOTS

Orencia may be used as monotherapy or concomitantly with diseasemodifying antirheumatic drugs (DMARDs) other than tumor necrosis factor (TNF) antagonists.

  • Anti Rheumatic
  • Monoclonal Antibody
  • World
  • Product Initiative
  • Pfizer Inc.

The prominent features of this report are - ##.

  • Anti Rheumatic
  • Arthritis
  • Clinical Trial
  • Pharmaceutical
  • World
  • Clinical Trial Profile Snapshots

The Impact of Antirheumatic Treatment on Antibody Response and Protection of Infections (Vaccimil) Vaccination in Inflammatory Rheumatic Disease (VACCIMIL).

  • Anti Rheumatic
  • Musculoskeletal Disorder
  • Pharmaceutical
  • World
  • Product Initiative